PNUEMOVAX 23 iCVA

The core visual aid is the source of truth for any pharmaceutical campaign. It is the asset that all content must ladder back to. With an exciting updated CDC recommendation on the horizon for their brand, PNEUMOVAX 23 was energized to revamp their iCVA and get their field team charged up to spread the news of their new treatment algorithm. The legacy vaccine helps prevent pneumococcal pneumonia for those 65+ or with a relevant comorbidity, like diabetes or COPD. Having gone some time between iCVA updates, this presented an excellent opportunity for the team to build an impactful piece the field could be proud of. 

Built to replace a text-heavy document that lived as three separate iCVAs (65+, comorbidity, and pharmacy), the team brought life to the brand with a streamlined user experience, including seamless navigation between impactful interactive content modules, making for a easy-to-follow pneumococcal vaccination presentation.